Scholar Rock Holding (SRRK) Interest & Investment Income (2024 - 2026)

Scholar Rock Holding's (SRRK) quarterly Interest & Investment Income came in at $2.9 million in Q1 2026, down 30.6% year-on-year from $4.2 million in Q1 2025, and down 16.76% quarter-over-quarter from $3.5 million in Q4 2025.

Scholar Rock Holding (SRRK) Interest & Investment Income (2024 - 2026) Analysis & Trends

Scholar Rock Holding's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $2.9 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 30.6% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $12.6 million, a 7.26% decrease from a year earlier, with the FY2025 full-year figure at $13.9 million, up 9.6% from the prior year.
  • Interest & Investment Income fell to $2.9 million in Q1 2026 per SRRK's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $4.6 million in Q4 2024 and bottomed at $2.1 million in Q3 2024.
  • The 3-year median for Interest & Investment Income is $3.3 million (2024), against an average of $3.3 million.
  • Across the five-year window, Interest & Investment Income jumped 31.2% in 2025 and tumbled 30.6% in 2026, its largest moves.
  • Year by year, Interest & Investment Income stood at $4.6 million in 2024, then decreased by 22.69% to $3.5 million in 2025, then retreated by 16.76% to $2.9 million in 2026.
  • Per Business Quant, the three latest SRRK Interest & Investment Income figures stand at $2.9 million (Q1 2026), $3.5 million (Q4 2025), and $2.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 27.66 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 114.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -65.80 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 44.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 19.51 Mn
10 Scholar Rock Holding 6.10 Bn 6.10 Bn - 2.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.94 Mn
Dec 31, 2025 3.53 Mn
Sep 30, 2025 2.73 Mn
Jun 30, 2025 3.41 Mn
Mar 31, 2025 4.23 Mn
Dec 31, 2024 4.56 Mn
Sep 30, 2024 2.08 Mn
Jun 30, 2024 2.72 Mn
Mar 31, 2024 3.32 Mn